RNA sequencing: new technologies and applications in cancer research

Abstract

Over the past few decades, RNA sequencing has significantly progressed, becoming a paramount approach for transcriptome profiling. The revolution from bulk RNA sequencing to single-molecular, single-cell and spatial transcriptome approaches has enabled increasingly accurate, individual cell resolution incorporated with spatial information. Cancer, a major malignant and heterogeneous lethal disease, remains an enormous challenge in medical research and clinical treatment. As a vital tool, RNA sequencing has been utilized in many aspects of cancer research and therapy, including biomarker discovery and characterization of cancer heterogeneity and evolution, drug resistance, cancer immune microenvironment and immunotherapy, cancer neoantigens and so on. In this review, the latest studies on RNA sequencing technology and their applications in cancer are summarized, and future challenges and opportunities for RNA sequencing technology in cancer applications are discussed.

Cited by papers we hold 6

• Tumor biomarkers for diagnosis, prognosis and targeted therapy · 2024
  No notice
• Liquid biopsy in cancer: current status, challenges and future prospects · 2024
  No notice
• Advances in single-cell RNA sequencing and its applications in cancer research · 2023
  No notice
• Next-Generation Sequencing Technology: Current Trends and Advancements · 2023
  Corrected
• Single-cell sequencing and establishment of an 8-gene prognostic model for pancreatic cancer patients · 2022
  Not checked
• Applications of single-cell sequencing in cancer research: progress and perspectives · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.